{ "items": [ "\n\n
\n \n\n \n \n \n \n SMRU\n \n \n\n \n\n\n
\n \n\n \n29 November 2022
\n \n \n \nA new WWARN meta-analysis, commissioned by the World Health Organization and which informed a change to its treatment guidelines, has been published in The Lancet. The study provides compelling evidence that artemether-lumefantrine should now replace quinine as the treatment of choice in the first trimester.
\n \n\n \n \n\n \n\n \n \n \n \n SMRU\n \n \n\n \n\n\n
\n \n\n \n29 November 2022
\n \n \n \nToday saw the long-awaited grand opening of the new Shoklo Malaria Research Unit (SMRU) / Borderland Health Foundation (BHF) Admin Building in Mae Ramat, Thailand, near the Thai-Myanmar border. And, boy was it worth the wait! Years in the planning, the very impressive new Admin Building looked absolutely stunning, the siting and architecture being universally admired by the many guests.
\n \n\n \n \n\n \n\n \n \n \n \n COMRU\n \n \n \n \n LOMWRU\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n22 November 2022
\n \n \n \nData showing 7.7 million deaths from 33 bacterial infections can guide measures to strengthen health systems, particularly in low-income settings
\n \n\n \n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n26 October 2022
\n \n \n \nMORU research has contributed to strategies to eliminate malaria in the Greater Mekong Sub-region, helping to prevent the spread of drug-resistant malaria and improving health provision and outcomes for remote communities.
\n \n\n \n \n\n \n\n \n \n \n \n COMRU\n \n \n \n \n SMRU\n \n \n\n \n\n\n
\n \n\n \n19 October 2022
\n \n \n \nA study of the genetic diversity of Streptococcus pneumoniae, the bacterium responsible for hundreds of thousands of infant deaths each year, found that deep sequencing whole pneumococcal populations gave unsurpassed sensitivity for detecting multiple colonisations and was twice as effective at detecting invasive virulent strains of the bacteria as current best methods, say researchers in a study published in Nature Microbiology.
\n \n\n \n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n28 September 2022
\n \n \n \nGiving people antimalarials during and after visiting the forest reduced their risk of contracting malaria 6-fold, and could be the missing piece towards eliminating malaria in Asia-Pacific and South America, say Mahidol and Oxford University researchers in a study published in The Lancet Infectious Diseases.
\n \n\n \n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n31 August 2022
\n \n \n \nThe joint MORU and IDDO Study to review global COVID-19 therapeutics guidelines, led by PIs Cintia V. Cruz, Mia Cokljat and Philippe Gu\u00e9rin, is examining current national COVID-19 treatment recommendations to investigate the level of variation and whether they are consistent with WHO guidelines for the pharmacological prevention and treatment of COVID-19.
\n \n\n \n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n MOCRU\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n30 August 2022
\n \n \n \nThree MORU Network staff awarded full professorship at the Nuffield Department of Medicine, University of Oxford.
\n \n\n \n \n\n \n\n \n \n \n \n SMRU\n \n \n\n \n\n\n
\n \n\n \n30 August 2022
\n \n \n \nFetal abdomen growth and the mother\u2019s blood fat metabolites very early in pregnancy influence a child\u2019s weight, body fat, vision and neurodevelopment at 2 years of age
\n \n\n \n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n12 August 2022
\n \n \n \nResearchers have created a mathematical model to predict genetic resistance to antimalarial drugs in Africa to manage one of the biggest threats to global malarial control.
\n \n\n \n \n\n \n\n \n \n \n \n Conferences & meetings\n \n \n\n \n\n\n
\n \n\n \n6 August 2022
\n \n \n \nMORU\u2019s Medicine Quality Research Group (MQRG) organised a multidisciplinary hybrid meeting at Keble College, Oxford, 3-6 July for the Wellcome Collaborative Award-funded FORESFA project (\u2018Forensic epidemiology and impact of substandard and falsified antimicrobials on public health\u2019).
\n \n\n \n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n20 July 2022
\n \n \n \nPatients affected by COVID-19 should be treated according to the severity of their disease. However, not all key national or international organisations define severity in the same way. This imprecision in severity assessment compromises the validity of some therapeutic recommendations. Using individual patient data would better guide and improve therapeutic recommendations for COVID-19.
\n \n\n \n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n \n \n SMRU\n \n \n\n \n\n\n
\n \n\n \n28 June 2022
\n \n \n \nMicroscopic examination of Giemsa-stained blood films is key to quantifying and detecting malaria parasites but there can be difficulties in ensuring both a high-quality manual reading and inter-reader reliability. The EasyScan GO was developed as a potential solution to this, a microscopy device using machine-learning-based image analysis for automated parasite detection and quantification.
\n \n\n \n \n\n \n\n \n \n \n \n LOMWRU\n \n \n\n \n\n\n
\n \n\n \n20 June 2022
\n \n \n \nEncephalitis is a worldwide public health issue, with a substantially high burden among children in Southeast Asia. A large study of the causes of childhood encephalitis in SE Asia suggests that enhanced and effective vaccination against the Japanese encephalitis virus alone could reduce encephalitis prevalence by one third.
\n \n\n \n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n7 June 2022
\n \n \n \nDavid Warrell, our founding director, has been appointed by the Queen \u2018Knight Commander of the Order of St Michael and St George for services to global Health Research and Clinical Practice\u2019. Please join us in congratulating Sir David on receiving this richly deserved high honour!
\n \n\n \n \n\n \n\n \n \n \n \n LOMWRU\n \n \n\n \n\n\n
\n \n\n \n11 May 2022
\n \n \n \nOrganised by a grass-root community of thousands of scientists across the world, Pint of Science 2022 allows researchers in 25 countries and over 800 cities to share their latest findings with lay folk in interesting, informal settings. Lao PDR joined the global Pint of Science family on Monday 9 May, when the first-ever Pint of Science Laos kicked off!
\n \n\n \n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n25 April 2022
\n \n \n \nToday is World Malaria Day. The global fight against malaria is at a critical point. No new antimalarial drugs are expected in the near future, and if multi-drug resistant falciparum malaria becomes established in East Africa and spreads to other parts of Africa, millions will be at risk of drug-resistant malaria infection and death. The development of triple artemisinin-based combination therapies aims to prevent or delay the emergence of artemisinin and multi-drug resistant malaria in Africa.
\n \n\n \n \n\n \n\n \n \n \n \n COMRU\n \n \n\n \n\n\n
\n \n\n \n22 April 2022
\n \n \n \nIn regions where few people have received Covid-19 vaccines, health systems remain vulnerable to surges in SARS-CoV-2 infections. During the delta-wave of COVID-19 in India, for example, healthcare facilities and staff across the country struggled to cope with the surge in the number of cases of COVID-19 due to a shortage of hospital beds for people with severe cases, plus shortages of medicines and limited human resources.
\n \n\n \n \n\n \n\n \n \n \n \n SMRU\n \n \n\n \n\n\n
\n \n\n \n24 March 2022
\n \n \n \nIn 2022, tuberculosis (TB) remains a major global health problem, particularly in developing countries. On the Thai-Myanmar border, TB is an important problem among migrants, a vulnerable, very mobile population, with unstable, often difficult living conditions, insecure incomes, and poor access to health services.
\n \n\n \n \n\n \n\n \n \n \n \n MORU Bangkok\n \n \n\n \n\n\n
\n \n\n \n22 March 2022
\n \n \n \nA triple artemisinin-based combination therapy (TACT) of artemether-lumefantrine plus amodiaquine (AL+AQ) for uncomplicated falciparum malaria in areas with a high prevalence of artemisinin resistance is a well-tolerated, effective treatment for multidrug-resistant parasites, say a team of MORU-led researchers.
\n \n\n \n \n